MEKINIST vs SORAFENIB TOSYLATE

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 21, 2026·How we rate

Possible drug interaction. MEKINIST and SORAFENIB TOSYLATE are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	MEKINIST	SORAFENIB TOSYLATE
Rating	70/100	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	TRAMETINIB DIMETHYL SULFOXIDE	SORAFENIB TOSYLATE
Manufacturer	Novartis	Yabao Pharm
Dosage forms	Powder, Tablet	Tablet
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	None	None
Treats	Non-Small-Cell Lung Carcinoma, Melanoma	Renal Cell Carcinoma, Hepatocellular Carcinoma, Thyroid Neoplasms

mekinist sorafenib tosylate

Rating

70/100

New

Pharmacy pays

—

Type

Active ingredient

TRAMETINIB DIMETHYL SULFOXIDE

SORAFENIB TOSYLATE

Manufacturer

Novartis

Yabao Pharm

Dosage forms

Powder, Tablet

Tablet

Drug class

Kinase Inhibitor

Boxed warning

None

Treats

Non-Small-Cell Lung Carcinoma, Melanoma

Renal Cell Carcinoma, Hepatocellular Carcinoma, Thyroid Neoplasms

Frequently asked questions

What is the difference between Mekinist and Sorafenib Tosylate?

Mekinist contains Trametinib Dimethyl Sulfoxide, while Sorafenib Tosylate contains Sorafenib Tosylate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.